Sudarshan Chemical Industries (506655) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
9 Sep, 2026Deal rationale and strategic fit
Acquisition expands global manufacturing footprint to 19 sites in 11 countries, supporting ambitions to be among the top three pigment players worldwide.
Access to advanced pigment technology, a broad product portfolio, and major geographies and industry segments.
Opportunity to integrate a strong customer base and experienced management from the acquired business.
Addresses Heubach's recent financial challenges with a clear turnaround plan.
Financial terms and conditions
Purchase price set at Rs 1,180 Cr / EUR 127.5 Mn on a debt-free basis.
Additional cash infusion of Rs 925 Cr / EUR 100 Mn for working capital, restructuring, and regulatory requirements.
Acquisition funded through a mix of debt and equity.
Deal expected to close in Q1 CY2025 or within 3-4 months, subject to regulatory and shareholder approvals.
Synergies and expected cost savings
Integration aims to create significant synergies in SG&A, manufacturing, procurement, and R&D.
Restructuring operations at underperforming sites and shifting select production.
Optimization of SG&A, including potential use of Global Business Services for non-critical roles.
IT integration and procurement optimization targeted for cost savings.
Combines R&D, innovation, and global supply chain networks for efficient customer service.
Latest events from Sudarshan Chemical Industries
- Revenue and margins rose, with normalized profit and improved financial strength.506655
Q1 24/25 - Record revenue and profit growth, margin expansion, and major global acquisition approved.506655
Q2 24/25 - Record revenue and profit growth in Q3/9M FY25, with strong pigment exports and acquisition-driven expansion.506655
Q3 24/25 - Heubach acquisition drove strong revenue and EBITDA growth, but net profit declined on costs.506655
Q4 24/25 - Q1 FY26 sales reached ₹2,507 Cr and EBITDA rose, but margins and net profit ratio declined.506655
Q1 25/26 - Pigments-led growth and Heubach acquisition drove higher revenue, with integration costs impacting profit.506655
Q2 25/26 - Revenue growth from acquisition offset by integration and regulatory costs, resulting in a net loss.506655
Q3 25/26 - Record revenue and EBITDA growth achieved, with Heubach integration and debt reduction progressing.506655
Q4 25/26 - Q1 FY27 saw robust revenue, profit, and EBITDA growth, with ongoing integration and restructuring.506655
Q1 26/27